Syed O Hasan

Array ( [id] => 15355497 [patent_doc_number] => 10526349 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-07 [patent_title] => Process of making cenicriviroc and related analogs [patent_app_type] => utility [patent_app_number] => 15/539279 [patent_app_country] => US [patent_app_date] => 2015-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13798 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10760696 [patent_doc_number] => 20160106849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-21 [patent_title] => 'FORMULATIONS OF PHENYL URACIL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 14/979013 [patent_app_country] => US [patent_app_date] => 2015-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16387 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14979013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12466359 [patent_doc_number] => 09987361 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2018-06-05 [patent_title] => Compositions and method for sustained drug delivery by active transdermal technology [patent_app_type] => utility [patent_app_number] => 14/974782 [patent_app_country] => US [patent_app_date] => 2015-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 8065 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14974782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13986271 [patent_doc_number] => 20190062293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-28 [patent_title] => METAL-ORGANIC FRAMEWORKS FOR THE CONVERSION OF LIGNOCELLULOSIC DERIVATIVES TO RENEWABLE PLATFORM CHEMICALS [patent_app_type] => utility [patent_app_number] => 15/539122 [patent_app_country] => US [patent_app_date] => 2015-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5092 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10750770 [patent_doc_number] => 20160096921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-07 [patent_title] => 'CAYALYST SYSTEM' [patent_app_type] => utility [patent_app_number] => 14/970551 [patent_app_country] => US [patent_app_date] => 2015-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4249 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14970551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14791361 [patent_doc_number] => 10398665 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-03 [patent_title] => Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction [patent_app_type] => utility [patent_app_number] => 14/969573 [patent_app_country] => US [patent_app_date] => 2015-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8730 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14969573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10754955 [patent_doc_number] => 20160101107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-14 [patent_title] => 'COMPOUNDS AS MODULATORS OF A MUTANT CFTR PROTEIN AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH CFTR PROTEIN MALFUNCTION' [patent_app_type] => utility [patent_app_number] => 14/969598 [patent_app_country] => US [patent_app_date] => 2015-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10423 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14969598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15068347 [patent_doc_number] => 10463639 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-05 [patent_title] => Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction [patent_app_type] => utility [patent_app_number] => 14/969609 [patent_app_country] => US [patent_app_date] => 2015-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8728 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14969609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11963543 [patent_doc_number] => 20170267695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-21 [patent_title] => 'ERK INHIBITORS' [patent_app_type] => utility [patent_app_number] => 15/531771 [patent_app_country] => US [patent_app_date] => 2015-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50514 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15531771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12058580 [patent_doc_number] => 20170334923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-23 [patent_title] => 'OPIOID RECEPTOR MODULATORS' [patent_app_type] => utility [patent_app_number] => 15/528339 [patent_app_country] => US [patent_app_date] => 2015-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 65615 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15528339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13106673 [patent_doc_number] => 10071969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-11 [patent_title] => Methods for the synthesis of activated ethylfumarates and their use as intermediates [patent_app_type] => utility [patent_app_number] => 14/949489 [patent_app_country] => US [patent_app_date] => 2015-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 30 [patent_no_of_words] => 11353 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14949489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11548401 [patent_doc_number] => 09617231 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-11 [patent_title] => 'Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia' [patent_app_type] => utility [patent_app_number] => 14/941800 [patent_app_country] => US [patent_app_date] => 2015-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 19 [patent_no_of_words] => 21206 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14941800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10721102 [patent_doc_number] => 20160067249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-10 [patent_title] => '3-Aryl-2-((Arylamino)Methyl)Quinazolin-4-(3H)-Ones' [patent_app_type] => utility [patent_app_number] => 14/940230 [patent_app_country] => US [patent_app_date] => 2015-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32188 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14940230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12999861 [patent_doc_number] => 10023588 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-17 [patent_title] => Compositions and methods for treating cancer [patent_app_type] => utility [patent_app_number] => 14/934184 [patent_app_country] => US [patent_app_date] => 2015-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 61027 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 308 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14934184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10776177 [patent_doc_number] => 20160122331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-05 [patent_title] => 'SUBSTITUTED TETRAHYDROPYRANS AND METHOD OF USE' [patent_app_type] => utility [patent_app_number] => 14/926727 [patent_app_country] => US [patent_app_date] => 2015-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 95715 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14926727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12023585 [patent_doc_number] => 20170313684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'PYRAZOLE OREXIN RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 15/523257 [patent_app_country] => US [patent_app_date] => 2015-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14379 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15523257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12030766 [patent_doc_number] => 20170320865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-09 [patent_title] => 'OXAZOLE OREXIN RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 15/523247 [patent_app_country] => US [patent_app_date] => 2015-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28237 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15523247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11625153 [patent_doc_number] => 20170135342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-18 [patent_title] => 'NOVEL TRISCATIONIC AMPHIPHILE COMPOUNDS, COMPOSITIONS, AND METHODS FOR MAKING SAME' [patent_app_type] => utility [patent_app_number] => 14/922126 [patent_app_country] => US [patent_app_date] => 2015-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16935 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14922126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12408270 [patent_doc_number] => 09969688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-15 [patent_title] => Roflumilast prodrugs [patent_app_type] => utility [patent_app_number] => 15/502793 [patent_app_country] => US [patent_app_date] => 2015-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4921 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15502793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14597041 [patent_doc_number] => 10351705 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-16 [patent_title] => Color material dispersion liquid for color filter, color resin composition for color filter, color material, color filter, liquid crystal display device, and light-emitting display device [patent_app_type] => utility [patent_app_number] => 15/539024 [patent_app_country] => US [patent_app_date] => 2015-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 21370 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539024 [rel_patent_id] =>[rel_patent_doc_number] =>)